Targeting of a Bile Acid Receptor, Takeda G Protein Receptor 5 [TGR5], by a Novel First-in-Class Competitive Antagonist, SBI-364, Diminishes Hepatic and Renal Cystogenesis in Polycystic Liver and Kidney Disease
新型首创竞争性拮抗剂SBI-364靶向胆汁酸受体——武田G蛋白受体5 [TGR5]，可减少多囊肝肾疾病中的肝肾囊肿形成。
期刊:ACS Pharmacology and Translational Science
影响因子:3.7
doi:10.1021/acsptsci.4c00701
Masyuk, Tetyana; Masyuk, Anatoliy; Trussoni, Christy; Lorenzo-Pisarello, Maria; Ardecky, Robert; Pinkerton, Anthony; Sergienko, Edward; Olson, Steven; Zou, Jiwen; Ganji, Santhi Reddy; Kramer, Bryan; Vuong, Krystine; Jankowski, She-Chia; Ma, Chen-Ting; Holleran, John; Pollari, Sirkku; Brown, Brock; Ramachandra, Raghuveer; Chung, Thomas; Turner, Carys; Morgenthaler, Olivia; Kawashima, Hanako; LaRusso, Nicholas
